Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Invasive Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: Anastrazole
Sponsor: University of Kansas Medical Center
Collaborators: AstraZeneca